MLchartDataset catalogue

LEP-ETU

Term · Oncology and biomedicine · MLC-T-ONC-004779

A form of the anticancer drug paclitaxel that is contained in very tiny, fat-like particles. It may have fewer side effects and work better than paclitaxel. It is being studied in the treatment of several types of cancer. LEP-ETU blocks the ability of cells to divide and may kill cancer cells. It is a type of mitotic inhibitor and a type of antimicrotubule agent. Also called liposomal paclitaxel, LipoTaxen, paclitaxel liposome, and PNU-93914.

Table 1. Record
IdentifierMLC-T-ONC-004779
FieldOncology and biomedicine
Expansionsliposomal paclitaxel; LipoTaxen; paclitaxel liposome
SynonymsPNU-93914
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-004779",
  "term": "LEP-ETU",
  "field": "Oncology and biomedicine",
  "definition": "A form of the anticancer drug paclitaxel that is contained in very tiny, fat-like particles. It may have fewer side effects and work better than paclitaxel. It is being studied in the treatment of several types of cancer. LEP-ETU blocks the ability of cells to divide and may kill cancer cells. It is a type of mitotic inhibitor and a type of antimicrotubule agent. Also called liposomal paclitaxel, LipoTaxen, paclitaxel liposome, and PNU-93914.",
  "expansions": [
    "liposomal paclitaxel",
    "LipoTaxen",
    "paclitaxel liposome"
  ],
  "synonyms": [
    "PNU-93914"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/lep-etu/"
}

Record 10,016 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.